The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
The role of the supply chain is more important in health care than ever before due to the rising economic challenges that are faced today. This three…
Podcasts
Research has shown that at least 2/3 of leaders in healthcare supply chain are having real issues locating candidates with the necessary competenci
Podcasts
As we redefine healthcare into a value-based service, it is critical to develop the type of partner relationship where trust and respect are at the
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or